IRIS Accounts Production v26.1.0.640 06245964 Board of Directors 1.12.24 30.11.25 30.11.25 Medium entities sale of timber based products. true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh062459642024-11-30062459642025-11-30062459642024-12-012025-11-30062459642023-11-30062459642023-12-012024-11-30062459642024-11-3006245964ns15:EnglandWales2024-12-012025-11-3006245964ns14:PoundSterling2024-12-012025-11-3006245964ns10:Director12024-12-012025-11-3006245964ns10:PrivateLimitedCompanyLtd2024-12-012025-11-3006245964ns10:MediumEntities2024-12-012025-11-3006245964ns10:Audited2024-12-012025-11-3006245964ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-12-012025-11-3006245964ns10:Medium-sizedCompaniesRegimeForAccounts2024-12-012025-11-3006245964ns10:FullAccounts2024-12-012025-11-3006245964ns10:OrdinaryShareClass12024-12-012025-11-3006245964ns10:Director22024-12-012025-11-3006245964ns10:Director32024-12-012025-11-3006245964ns10:Director42024-12-012025-11-3006245964ns10:Director52024-12-012025-11-3006245964ns10:CompanySecretary12024-12-012025-11-3006245964ns10:RegisteredOffice2024-12-012025-11-3006245964ns5:CurrentFinancialInstruments2025-11-3006245964ns5:CurrentFinancialInstruments2024-11-3006245964ns5:ShareCapital2025-11-3006245964ns5:ShareCapital2024-11-3006245964ns5:RetainedEarningsAccumulatedLosses2025-11-3006245964ns5:RetainedEarningsAccumulatedLosses2024-11-3006245964ns5:ShareCapital2023-11-3006245964ns5:RetainedEarningsAccumulatedLosses2023-11-3006245964ns5:RetainedEarningsAccumulatedLosses2023-12-012024-11-3006245964ns5:RetainedEarningsAccumulatedLosses2024-12-012025-11-3006245964ns5:FurnitureFittings2024-12-012025-11-3006245964ns5:ComputerEquipment2024-12-012025-11-3006245964ns5:OwnedAssets2024-12-012025-11-3006245964ns5:OwnedAssets2023-12-012024-11-300624596412024-12-012025-11-300624596412023-12-012024-11-3006245964132024-12-012025-11-3006245964132023-12-012024-11-3006245964ns10:OrdinaryShareClass12023-12-012024-11-3006245964ns5:FurnitureFittings2024-11-3006245964ns5:ComputerEquipment2024-11-3006245964ns5:FurnitureFittings2025-11-3006245964ns5:ComputerEquipment2025-11-3006245964ns5:FurnitureFittings2024-11-3006245964ns5:ComputerEquipment2024-11-3006245964ns5:WithinOneYearns5:CurrentFinancialInstruments2025-11-3006245964ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3006245964ns5:WithinOneYear2025-11-3006245964ns5:WithinOneYear2024-11-3006245964ns5:BetweenOneFiveYears2025-11-3006245964ns5:BetweenOneFiveYears2024-11-3006245964ns5:MoreThanFiveYears2025-11-3006245964ns5:MoreThanFiveYears2024-11-3006245964ns5:AllPeriods2025-11-3006245964ns5:AllPeriods2024-11-3006245964ns10:OrdinaryShareClass12025-11-3006245964ns5:RetainedEarningsAccumulatedLosses2024-11-3006245964ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2024-12-012025-11-3006245964ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2023-12-012024-11-3006245964ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2025-11-3006245964ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2024-11-3006245964ns5:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl2024-12-012025-11-3006245964ns5:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl2025-11-3006245964ns5:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl2024-11-30
REGISTERED NUMBER: 06245964 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 30 November 2025

for

Altripan UK Limited

Altripan UK Limited (Registered number: 06245964)

Contents of the Financial Statements
for the year ended 30 November 2025










Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 8

Other Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Cash Flow Statement 12

Notes to the Cash Flow Statement 13

Notes to the Financial Statements 14


Altripan UK Limited

Company Information
for the year ended 30 November 2025







Directors: A Simpson
M Walduck
K J De Witte
M L Giles
B Clarysse



Secretary: W J Price



Registered office: 32 Monk Street
Abergavenny
Monmouthshire
NP7 5HW



Registered number: 06245964 (England and Wales)



Senior statutory auditor: Robin Mason FCCA



Auditors: Acre Accountancy Limited
Statutory Auditor
Certified Accountants
Unit 2 Foley Works
Foley Trading Estate
Hereford
Herefordshire
HR1 2SF

Altripan UK Limited (Registered number: 06245964)

Strategic Report
for the year ended 30 November 2025


The directors present their strategic report for the year ended 30 November 2025.

Review of business
The principal activity of the company was that of sale of timber based products. The directors do not plan to change these activities in the foreseeable future.

Development and performance
The directors are happy with this year's figures. In this current financial period we continue to see an improvement.

The company uses the following Key Performance Indicators to measure its ongoing performance:-
- gross profit and contribution percentage - in total, by customer, by product group, by product
- distribution, wages, overheads costs as a percentage of sales.

Principal risks and uncertainties
The directors aim to ensure that financial and compliance risks to the business are minimised through good management. This includes:

- ensuring that the risk of exposure to foreign currency losses is minimised
- increasing cashflow by adopting invoice discounting
- employing sensible credit control procedures to minimise bad debts
- forward sales to ensure volume to gain lower margin
- ensuring all assets are secure and adequately insured
- ensuring products are up to adequate standard by conducting relevant testing

On behalf of the board:





M Walduck - Director


20 March 2026

Altripan UK Limited (Registered number: 06245964)

Report of the Directors
for the year ended 30 November 2025


The directors present their report with the financial statements of the company for the year ended 30 November 2025.

Dividends
Interim dividends were paid on a monthly basis during the year on W & S Ordinary shares totalling £205,427 (£4,280 per share (2024: £205,427 (£4,280 per share)).

Further interim dividends were paid in March 2025 as below:-

Ordinary shares £365,124 (£11,064.33 per share)
W Ordinary shares £81,823 (£3,409.29 per share)
S Ordinary shares £171,823 (£7,159.29 per share)


No final dividend has been declared this year (2024: £nil).

Directors
The directors shown below have held office during the whole of the period from 1 December 2024 to the date of this report.

A Simpson
M Walduck
K J De Witte

Other changes in directors holding office are as follows:

M L Giles - appointed 9 December 2024
B Clarysse - appointed 1 December 2024

Statement of directors' responsibilities
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement as to disclosure of information to auditors
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Altripan UK Limited (Registered number: 06245964)

Report of the Directors
for the year ended 30 November 2025


Auditors
The auditors, Acre Accountancy Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

On behalf of the board:





M Walduck - Director


20 March 2026

Report of the Independent Auditors to the Members of
Altripan UK Limited


Opinion
We have audited the financial statements of Altripan UK Limited (the 'company') for the year ended 30 November 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 November 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Altripan UK Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We enquired with management about the legal framework that the company operates in. We also enquired about the risk of fraud and whether they were aware of any instances of fraud.

We communicated the outcome of this risk assessment with the audit team and planned our audit work accordingly. Our work in these areas is limited to analytical procedures and inspection of relevant documentation. Where a breach of operational regulations is not disclosed to us, or it is not evident from documentation that we receive during the audit, an audit will not detect that breach.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Altripan UK Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Robin Mason FCCA (Senior Statutory Auditor)
for and on behalf of Acre Accountancy Limited
Statutory Auditor
Certified Accountants
Unit 2 Foley Works
Foley Trading Estate
Hereford
Herefordshire
HR1 2SF

20 March 2026

Altripan UK Limited (Registered number: 06245964)

Income Statement
for the year ended 30 November 2025

2025 2024
Notes £    £   

TURNOVER 23,053,650 21,863,913

Cost of sales (20,817,787 ) (19,203,369 )
GROSS PROFIT 2,235,863 2,660,544

Administrative expenses (856,290 ) (797,377 )
1,379,573 1,863,167

Other operating income 15,971 -
OPERATING PROFIT 4 1,395,544 1,863,167


Interest payable and similar expenses 5 (309,431 ) (301,226 )
PROFIT BEFORE TAXATION 1,086,113 1,561,941

Tax on profit 6 (285,464 ) (389,735 )
PROFIT FOR THE FINANCIAL YEAR 800,649 1,172,206

Altripan UK Limited (Registered number: 06245964)

Other Comprehensive Income
for the year ended 30 November 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 800,649 1,172,206


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

800,649

1,172,206

Altripan UK Limited (Registered number: 06245964)

Balance Sheet
30 November 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 8 2,153 3,643

CURRENT ASSETS
Stocks 9 5,953,317 8,024,556
Debtors 10 3,263,252 3,910,816
9,216,569 11,935,372
CREDITORS
Amounts falling due within one year 11 (5,370,074 ) (8,066,820 )
NET CURRENT ASSETS 3,846,495 3,868,552
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,848,648

3,872,195

CAPITAL AND RESERVES
Called up share capital 15 99 99
Retained earnings 16 3,848,549 3,872,096
SHAREHOLDERS' FUNDS 3,848,648 3,872,195

The financial statements were approved by the Board of Directors and authorised for issue on 20 March 2026 and were signed on its behalf by:





M Walduck - Director


Altripan UK Limited (Registered number: 06245964)

Statement of Changes in Equity
for the year ended 30 November 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 December 2023 99 2,905,317 2,905,416

Changes in equity
Dividends - (205,427 ) (205,427 )
Total comprehensive income - 1,172,206 1,172,206
Balance at 30 November 2024 99 3,872,096 3,872,195

Changes in equity
Dividends - (824,196 ) (824,196 )
Total comprehensive income - 800,649 800,649
Balance at 30 November 2025 99 3,848,549 3,848,648

Altripan UK Limited (Registered number: 06245964)

Cash Flow Statement
for the year ended 30 November 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,642,696 (345,053 )
Interest paid (169,262 ) (110,302 )
Finance costs paid (140,169 ) (190,924 )
Tax paid (634,331 ) -
Net cash from operating activities 698,934 (646,279 )

Cash flows from investing activities
Purchase of tangible fixed assets - (4,491 )
Net cash from investing activities - (4,491 )

Cash flows from financing activities
Amount introduced by directors 22,118 25,140
Amount withdrawn by directors (25,140 ) (18,312 )
Equity dividends paid (824,196 ) (205,427 )
Net cash from financing activities (827,218 ) (198,599 )

Decrease in cash and cash equivalents (128,284 ) (849,369 )
Cash and cash equivalents at beginning of
year

2

(1,440,367

)

(590,998

)

Cash and cash equivalents at end of year 2 (1,568,651 ) (1,440,367 )

Altripan UK Limited (Registered number: 06245964)

Notes to the Cash Flow Statement
for the year ended 30 November 2025


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2025 2024
£    £   
Profit before taxation 1,086,113 1,561,941
Depreciation charges 1,490 1,490
Finance costs 309,431 301,226
1,397,034 1,864,657
Decrease/(increase) in stocks 2,071,239 (3,645,810 )
Decrease/(increase) in trade and other debtors 642,160 (148,520 )
(Decrease)/increase in trade and other creditors (2,467,737 ) 1,584,620
Cash generated from operations 1,642,696 (345,053 )

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 November 2025
30.11.25 1.12.24
£    £   
Bank overdrafts (1,568,651 ) (1,440,367 )
Year ended 30 November 2024
30.11.24 1.12.23
£    £   
Bank overdrafts (1,440,367 ) (590,998 )


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.12.24 Cash flow At 30.11.25
£    £    £   
Net cash
Bank overdrafts (1,440,367 ) (128,284 ) (1,568,651 )
(1,440,367 ) (128,284 ) (1,568,651 )
Total (1,440,367 ) (128,284 ) (1,568,651 )

Altripan UK Limited (Registered number: 06245964)

Notes to the Financial Statements
for the year ended 30 November 2025


1. STATUTORY INFORMATION

Altripan UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

With regard to transactions with Altripan NV, these are either translated at the rate at the date of transaction or, where appropriate, exchanged at an agreed rate between the two parties which reflects exchange rate contracts held by Altripan NV.

Altripan UK Limited (Registered number: 06245964)

Notes to the Financial Statements - continued
for the year ended 30 November 2025


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for according to the substance of the contractual arrangement. They are classified as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Invoice discounting
The company has entered into an invoice discounting agreement for certain trade debtors. Amounts due from the customer are shown in full in trade debtors, with amounts due to the finance company shown in creditors due within twelve months within other creditors.

3. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 365,938 355,485
Social security costs 49,316 35,626
Other pension costs 132,307 6,674
547,561 397,785

The average number of employees during the year was as follows:
2025 2024

Directors 5 4
Sales and Administration 4 5
9 9

2025 2024
£    £   
Directors' remuneration 170,222 30,070
Directors' pension contributions to money purchase schemes 121,761 -

Altripan UK Limited (Registered number: 06245964)

Notes to the Financial Statements - continued
for the year ended 30 November 2025


4. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2025 2024
£    £   
Other operating leases 24,107 13,835
Depreciation - owned assets 1,490 1,490
Auditors' remuneration 10,250 8,900
Auditors' remuneration for non audit work 9,100 9,100
Foreign exchange differences (76,502 ) 21,058

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank interest 169,637 110,302
HMRC credit interest (375 ) -
Interest on other loans 140,169 190,924
309,431 301,226

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 285,464 389,735
Tax on profit 285,464 389,735

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 1,086,113 1,561,941
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

271,528

390,485

Effects of:
Expenses not deductible for tax purposes 13,564 -
corporation tax rate
Deferred tax not provided 2025 (539 ) (911 )
Deferred tax not provided prior year 911 161
Total tax charge 285,464 389,735

Altripan UK Limited (Registered number: 06245964)

Notes to the Financial Statements - continued
for the year ended 30 November 2025


7. DIVIDENDS
2025 2024
£    £   
Ordinary shares of £1 each
Interim 824,196 205,427

8. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
Cost
At 1 December 2024
and 30 November 2025 8,648 50,107 58,755
Depreciation
At 1 December 2024 7,461 47,651 55,112
Charge for year 905 585 1,490
At 30 November 2025 8,366 48,236 56,602
Net book value
At 30 November 2025 282 1,871 2,153
At 30 November 2024 1,187 2,456 3,643

9. STOCKS
2025 2024
£    £   
Stocks 5,953,317 8,024,556

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 3,154,098 3,905,412
Tax - 5,404
VAT 109,154 -
3,263,252 3,910,816

Altripan UK Limited (Registered number: 06245964)

Notes to the Financial Statements - continued
for the year ended 30 November 2025


11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 12) 1,568,651 1,440,367
Trade creditors 975,713 2,847,794
Tax 35,464 389,735
Social security and other taxes - 10,128
VAT - 740,581
Other creditors 2,469,777 2,168,940
Directors' current accounts 22,118 25,140
Deferred income - 176,230
Accrued expenses 298,351 267,905
5,370,074 8,066,820

12. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 1,568,651 1,440,367

13. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year 14,227 25,519
Between one and five years 30,581 47,422
In more than five years 44,598 50,477
89,406 123,418

14. SECURED DEBTS

A Customs guarantee has been given to the ING bank N.V for the sum of £260,000.

15. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
99 Ordinary £1 99 99

The company has three designations of shares within ordinary capital which are equal as regards voting, distribution and capital return matters.

Altripan UK Limited (Registered number: 06245964)

Notes to the Financial Statements - continued
for the year ended 30 November 2025


16. RESERVES
Retained
earnings
£   

At 1 December 2024 3,872,096
Profit for the year 800,649
Dividends (824,196 )
At 30 November 2025 3,848,549

17. ULTIMATE PARENT COMPANY

Van Steenberge Invest NV (incorporated in Belgium ) is regarded by the directors as being the company's ultimate parent company.

18. RELATED PARTY DISCLOSURES

Entities with control, joint control or significant influence over the entity
2025 2024
£    £   
Purchases 14,059,590 16,674,914
Haulage, travel expenses, duty and reception costs 733,884 740,539
Interest charges 66,576 -
Amount due to related party 372,237 2,433,760

Key management personnel of the entity or its parent (in the aggregate)
2025 2024
£    £   
Amount due to related party 22,118 25,140

During the year, total dividends of £229,536 (2024: £102,713) were paid to close members of the key personnel's family.